SNDX
Price
$12.51
Change
+$0.03 (+0.24%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
1.08B
92 days until earnings call
SRPT
Price
$17.95
Change
-$0.28 (-1.54%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
1.78B
79 days until earnings call
Interact to see
Advertisement

SNDX vs SRPT

Header iconSNDX vs SRPT Comparison
Open Charts SNDX vs SRPTBanner chart's image
Syndax Pharmaceuticals
Price$12.51
Change+$0.03 (+0.24%)
Volume$43.58K
Capitalization1.08B
Sarepta Therapeutics
Price$17.95
Change-$0.28 (-1.54%)
Volume$106.28K
Capitalization1.78B
SNDX vs SRPT Comparison Chart in %
Loading...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNDX vs. SRPT commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNDX is a StrongBuy and SRPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (SNDX: $12.48 vs. SRPT: $18.23)
Brand notoriety: SNDX: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNDX: 135% vs. SRPT: 75%
Market capitalization -- SNDX: $1.08B vs. SRPT: $1.78B
SNDX [@Biotechnology] is valued at $1.08B. SRPT’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNDX’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • SNDX’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, SNDX is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNDX’s TA Score shows that 6 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • SNDX’s TA Score: 6 bullish, 4 bearish.
  • SRPT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than SRPT.

Price Growth

SNDX (@Biotechnology) experienced а +25.05% price change this week, while SRPT (@Biotechnology) price change was +14.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

SNDX is expected to report earnings on Nov 11, 2025.

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.78B) has a higher market cap than SNDX($1.08B). SNDX YTD gains are higher at: -5.598 vs. SRPT (-85.007). SRPT has higher annual earnings (EBITDA): -106.51M vs. SNDX (-318.27M). SRPT (523M) and SNDX (516M) have equal amount of cash in the bank . SNDX has less debt than SRPT: SNDX (1.84M) vs SRPT (1.34B). SRPT has higher revenues than SNDX: SRPT (2.23B) vs SNDX (43.7M).
SNDXSRPTSNDX / SRPT
Capitalization1.08B1.78B60%
EBITDA-318.27M-106.51M299%
Gain YTD-5.598-85.0077%
P/E RatioN/A27.21-
Revenue43.7M2.23B2%
Total Cash516M523M99%
Total Debt1.84M1.34B0%
FUNDAMENTALS RATINGS
SNDX vs SRPT: Fundamental Ratings
SNDX
SRPT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4695
P/E GROWTH RATING
1..100
4100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRPT's Valuation (60) in the Biotechnology industry is in the same range as SNDX (85). This means that SRPT’s stock grew similarly to SNDX’s over the last 12 months.

SRPT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SNDX (100). This means that SRPT’s stock grew similarly to SNDX’s over the last 12 months.

SRPT's SMR Rating (96) in the Biotechnology industry is in the same range as SNDX (98). This means that SRPT’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for SRPT (95). This means that SNDX’s stock grew somewhat faster than SRPT’s over the last 12 months.

SNDX's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for SRPT (100). This means that SNDX’s stock grew significantly faster than SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNDXSRPT
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 6 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQIAX41.540.25
+0.61%
Principal Equity Income A
EIVAX14.360.07
+0.49%
Allspring Special Large Cap Value A
PVFIX16.470.04
+0.24%
Pinnacle Value
GGESX24.920.05
+0.20%
Nationwide Global Sust Eq Instl Svc
IARAX16.47-0.16
-0.96%
Invesco Real Estate A

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-1.89%
IDYA - SNDX
52%
Loosely correlated
+3.08%
CGON - SNDX
51%
Loosely correlated
+2.05%
REPL - SNDX
50%
Loosely correlated
N/A
ETNB - SNDX
48%
Loosely correlated
+1.55%
RNA - SNDX
47%
Loosely correlated
-2.59%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with BPMUF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+1.50%
BPMUF - SRPT
52%
Loosely correlated
N/A
AAVXF - SRPT
45%
Loosely correlated
N/A
BHVN - SRPT
37%
Loosely correlated
-3.22%
SNDX - SRPT
35%
Loosely correlated
-1.89%
REPL - SRPT
34%
Loosely correlated
N/A
More